A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406)

NCT01587235 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: Ezetimibe/simvastatin
DRUG: Other Statin

Sponsor

Organon and Co